Immunogenicity of trivalent influenza vaccine in patients with lung cancer undergoing anticancer chemotherapy

References

• Cooksley CD, Avritscher EB, Bekele BN, Rolston KV, Geraci JM, Elting LS. Epidemiology and outcomes of serious influenza-related infections in the cancer population. Cancer 2005; 104:618-28; PMID:15973737; http://dx.doi.org/10.1002/cncr.21203
   PubMed Web of Science ®Google Scholar
• Kunisaki KM, Janoff EN. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 2009; 9:493-504; PMID:19628174; http://dx.doi.org/10.1016/S1473-3099(09)70175-6
   PubMed Web of Science ®Google Scholar
• Shehata MA, Karim NA. Influenza vaccination in cancer patients undergoing systemic therapy. Clin Med Insights Oncol 2014; 8:57-64; PMID:24855405
   PubMedGoogle Scholar
• Earle CC. Influenza vaccination in elderly patients with advanced colorectal cancer. J Clin Oncol 2003; 21:1161-6; PMID:12637485; http://dx.doi.org/10.1200/JCO.2003.06.008
   PubMed Web of Science ®Google Scholar
• Beck CR, McKenzie BC, Hashim AB, Harris RC, Zanuzdana A, Agboado G, Orton E, Bechard-Evans L, Morgan G, Stevenson C, et al. Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective. PLoS One 2011; 6:e29249; PMID:22216224; http://dx.doi.org/10.1371/journal.pone.0029249
   PubMed Web of Science ®Google Scholar
• Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2014; 58:309-18; PMID:24421306; http://dx.doi.org/10.1093/cid/cit816
   PubMed Web of Science ®Google Scholar
• Loulergue P, Mir O, Alexandre J, Ropert S, Goldwasser F, Launay O. Low influenza vaccination rate among patients receiving chemotherapy for cancer. Ann Oncol 2008; 19:1658; PMID:18662953; http://dx.doi.org/10.1093/annonc/mdn531
   PubMed Web of Science ®Google Scholar
• Meidani M, Rostami M, Dehghani F. Why coverage of influenza vaccine is not enough in patients receiving chemotherapy? Int J Prev Med 2011; 2:186-7; PMID:21811662
   PubMedGoogle Scholar
• Anderson H, Petrie K, Berrisford C, Charlett A, Thatcher N, Zambon M. Seroconversion after influenza vaccination in patients with lung cancer. Br J Cancer 1999; 80:219-20; PMID:10389999; http://dx.doi.org/10.1038/sj.bjc.6690342
   PubMed Web of Science ®Google Scholar
• Kim DH, Lee YY, Shin US, Moon SM. Immunogenicity of influenza vaccine in colorectal cancer patients. Cancer Res Treat 2013; 45:303-12; PMID:24454003; http://dx.doi.org/10.4143/crt.2013.45.4.303
   PubMedGoogle Scholar
• Xu Y, Methuku N, Coimbatore P, Fitzgerald T, Huang Y, Xiao YY, Pagala M, Gupta S, Solomon W, Rubin P, et al. Immunogenicity of an inactivated monovalent 2009 influenza A (H1N1) vaccine in patients who have cancer. Oncologist 2012; 17:125-34; PMID:22240540; http://dx.doi.org/10.1634/theoncologist.2011-0220
   PubMed Web of Science ®Google Scholar
• Global Burden of Disease Cancer Collaboration. Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, et al. The Global Burden of Cancer 2013. JAMA Oncol 2015; 1:505-27; PMID:26181261; http://dx.doi.org/10.1001/jamaoncol.2015.0735
   PubMed Web of Science ®Google Scholar
• Masters GA, Temin S, Azzoli CG, Giaccone G, Baker S, Jr, Brahmer JR, Ellis PM, Gajra A, Rackear N, Schiller JH, et al. Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 2015; 33:3488-515; PMID:26324367; http://dx.doi.org/10.1200/JCO.2015.62.1342
   PubMed Web of Science ®Google Scholar
• European Committee for Proprietary Medial Products. Note for Guidance on Harmonisation of Requirements for Influenza Vaccines (CPMP/BWP/214/96). London: European Agency Evaluation Medical Products, 1997.
   Google Scholar
• Center for Biologics Evaluation and Research. Guidance for industry: Clinical Data Needed to Support the Licensure of Seasonal Inactivated Influenza Vaccines. Food Drug Administration, 2007.
   Google Scholar
• Beck CR, McKenzie BC, Hashim AB, Harris RC, University of Nottingham I, the ImmunoCompromised Study G, Nguyen-Van-Tam JS. Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by etiology. J Infect Dis 2012; 206:1250-9; PMID:22904335; http://dx.doi.org/10.1093/infdis/jis487
   PubMed Web of Science ®Google Scholar
• Robertson JD, Nagesh K, Jowitt SN, Dougal M, Anderson H, Mutton K, Zambon M, Scarffe JH. Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. Br J Cancer 2000; 82:1261-5; PMID:10755398; http://dx.doi.org/10.1054/bjoc.1999.1088
   PubMed Web of Science ®Google Scholar
• Ljungman P, Nahi H, Linde A. Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised study. Br J Haematol 2005; 130:96-8; PMID:15982350; http://dx.doi.org/10.1111/j.1365-2141.2005.05582.x
   PubMed Web of Science ®Google Scholar
• Mazza JJ, Yale SH, Arrowood JR, Reynolds CE, Glurich I, Chyou PH, Linneman JG, Reed KD. Efficacy of the influenza vaccine in patients with malignant lymphoma. Clin Med Res 2005; 3:214-20; PMID:16303886; http://dx.doi.org/10.3121/cmr.3.4.214
   PubMedGoogle Scholar
• Yri OE, Torfoss D, Hungnes O, Tierens A, Waalen K, Nordoy T, Dudman S, Kilander A, Wader KF, Ostenstad B, et al. Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment. Blood 2011; 118:6769-71; PMID:22058114; http://dx.doi.org/10.1182/blood-2011-08-372649
   PubMed Web of Science ®Google Scholar
• Hodges GR, Davis JW, Lewis HD, Jr, Whittier FC, Jr, Siegel CD, Chin TD, Clark GM, Noble GR. Response to influenza A vaccine among high-risk patients. South Med J 1979; 72:29-32; PMID:366766; http://dx.doi.org/10.1097/00007611-197901000-00010
   PubMed Web of Science ®Google Scholar
• Brydak LB, Machala M, Centkowski P, Warzocha K, Bilinski P. Humoral response to hemagglutinin components of influenza vaccine in patients with non-Hodgkin malignant lymphoma. Vaccine 2006; 24:6620-3; PMID:16870313; http://dx.doi.org/10.1016/j.vaccine.2006.05.100
   PubMed Web of Science ®Google Scholar
• Puthillath A, Trump DL, Andrews C, Bir A, Romano K, Wisniewski M, Fakih MG. Serological immune responses to influenza vaccine in patients with colorectal cancer. Cancer Chemother Pharmacol 2011; 67:111-5; PMID:20204362; http://dx.doi.org/10.1007/s00280-010-1292-2
   PubMed Web of Science ®Google Scholar
• Brydak LB, Guzy J, Starzyk J, Machala M, Gozdz SS. Humoral immune response after vaccination against influenza in patients with breast cancer. Support Care Cancer 2001; 9:65-8; PMID:11147146; http://dx.doi.org/10.1007/s005200000186
   PubMed Web of Science ®Google Scholar
• Vilar-Compte D, Cornejo P, Valle-Salinas A, Roldan-Marin R, Iguala M, Cervantes Y, Lopez I. Influenza vaccination in patients with breast cancer: a case-series analysis. Med Sci Monit 2006; 12:CR332-6; PMID:16865064
   PubMedGoogle Scholar
• Kendal AP, Cate TR. Increased sensitivity and reduced specificity of hemagglutination inhibition tests with ether-treated influenza B/Singapore/222/79. J Clin Microbiol 1983; 18:930-4; PMID:6630472
   PubMed Web of Science ®Google Scholar
• Tsurudome Y, Kimachi K, Okada Y, Matsuura K, Ooyama Y, Ibaragi K, Kino Y, Ueda K. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine in healthy adults: a phase II, open-label, uncontrolled trial in Japan. Microbiol Immunol 2015; 59:597-604. accessed at ; PMID:26272602; http://dx.doi.org/10.1111/1348-0421.12316
   PubMed Web of Science ®Google Scholar
• Francis T, Salk JE, Quilligan JJ. Experience with vaccination against influenza in the spring of 1947: A preliminary report. Am J Public Health Nations Health 1947; 37:1013-6; http://dx.doi.org/10.2105/AJPH.37.8.1013
   PubMed Web of Science ®Google Scholar
• Ndifon W. A simple mechanistic explanation for original antigenic sin and its alleviation by adjuvants. J R Soc Interface 2015; 12:20150627; PMID:26577593; http://dx.doi.org/10.1098/rsif.2015.0627
   PubMed Web of Science ®Google Scholar
• Skowronski DM, Hottes TS, De Serres G, Ward BJ, Janjua NZ, Sabaiduc S, Chan T, Petric M. Influenza B/Victoria antigen induces strong recall of B/Yamagata but lower B/Victoria response in children primed with two doses of B/Yamagata. Pediatr Infect Dis J 2011; 30:833-9; PMID:21857263; http://dx.doi.org/10.1097/INF.0b013e31822db4dc
   PubMed Web of Science ®Google Scholar
• Ministry of Health, Labour and Welfare, Japan. Stratgey for prevention of influenza infection. Available at: http://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou01/dl/fludoco1415.pdf (accessed June 25, 2016)
   Google Scholar
• Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NJ, Centers for Disease C, Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recommendations Reports 2009; 58:1-52.
   PubMedGoogle Scholar
• Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2015. Available from: http://www.goldcopd.org/
   Google Scholar
• Poole PJ, Chacko E, Wood-Baker RW, Cates CJ. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006; CD002733; PMID:16437444
   PubMed Web of Science ®Google Scholar
• Nath KD, Burel JG, Shankar V, Pritchard AL, Towers M, Looke D, Davies JM, Upham JW. Clinical factors associated with the humoral immune response to influenza vaccination in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2014; 9:51-6; PMID:24399872
   PubMed Web of Science ®Google Scholar
• Qaseem A, Snow V, Shekelle P, Sherif K, Wilt TJ, Weinberger S, Owens DK, Clinical Efficacy Assessment Subcommittee of the American College of P. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Annals Internal Med 2007; 147:633-8; PMID:17975186; http://dx.doi.org/10.7326/0003-4819-147-9-200711060-00008
   PubMed Web of Science ®Google Scholar
• Hirst GK. The quantitative determination of influenza virus and antibodies by means of red cell agglutination. J Exp Med 1942; 75:49-64; PMID:19871167; http://dx.doi.org/10.1084/jem.75.1.49
   PubMedGoogle Scholar